...Jorge E. Arrese; Gérald E. Piérard The therapeutic outcome of onychomycoses is uncertain. Comparative short-term efficacy studies on antifungals abound and report contradictory findings. Few unbiased follow-up studies have scrutinized the long-term outcome. Basically, none of the current...

... Belgian mosque. The disease was unresponsive to current oral antifungal treatments. Onychomycosis is not a clinical diagnosis. The presence of a fungus must be confirmed by microscopy and by culture of the micro-organism as well. The importance of confirming the diagnosis cannot be overstressed since...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Seborrheic dermatitis Metronidazole Antifungal Seborrheic dermatitis is a common, chronic papulosquamous dermatosis which affects infants and adults and is often...

..., for example with the triazole antifungal itraconazole. Itraconazole can inhibit the metabolism of drugs by CYP 3A4 and therefore might affect the efficacy of antidiabetic agents. Objective: To investigate this, we assessed the safety of itraconazole in diabetic patients with onychomycosis or dermatomycoses...